Pharmaceuticals, Biotechnology and Life Sciences
11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response 12 of 12 participants (100%) in…
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage…
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable LawsTTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards…
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the…
Curated 5,500-Square-Foot Venue Launches June 14 Across from Chateau Marmont with Premium Brands, Gourmet Experiences, and Hollywood Design FlairWEST HOLLYWOOD,…
Aggregated presentation by day and by market Statement of transactions in own shares from June 2nd to June 6th 2025 Name…
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its…
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology…
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced…
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology…